Jump to content

Graham Colditz

From Wikipedia, the free encyclopedia

Graham Colditz
Born (1954-11-01) 1 November 1954 (age 69)
NationalityAustralian
EducationNewington College
University of Queensland
Harvard University
Occupation(s)Niess-Gain Professor
Washington University School of Medicine
Associate Director
Alvin J. Siteman Cancer Center
SpousePat Cox
Children1 son, 1 daughter

Graham Andrew Colditz MD, DrPH (born 1 November 1954) is an Australian chronic disease epidemiologist. He is the inaugural Niess-Gain Professor at Washington University School of Medicine, where he is associate director for Prevention and Control at the Alvin J. Siteman Cancer Center.[1] He directs the Master of Population Health Science at Washington University School of Medicine.[2] During medical training he was excited by the potential for prevention of chronic diseases. With encouragement from mentors he pursued training in the US as it was routine for academics in Australia to obtain overseas training at that time. He is internationally recognized for leadership in cancer prevention,[3] and is often interviewed by media for input on this topic. With members of Cancer Prevention and Control at Siteman, he blogs on issues relating to cancer prevention and screening.[4] According to Google Scholar statistics, Colditz has a h-index of more than 300.[5] Colditz was a member of the Institute of Medicine Committee to Review Adverse Effects of Vaccines but resigned, along with Ruby H. N. Nguyen, before it produced its seminal report.[6]

Birth and education

[edit]

Colditz was born in Australia and educated at Newington College (1967–72).[7] He was active in cricket and rugby at Newington. He received his B.Sc. and medical degree from the University of Queensland, Australia, where he served as President of the Australian Medical Students Association in 1977. He obtained his M.P.H. and Doctorate in Public Health from Harvard University School of Public Health.[8] Placing great importance on applying the scientific evidence amassed through research, Dr. Colditz has taken the lead on a number of large health communication projects, including the development of the long-running, popular health risk assessment, Your Disease Risk.[9][10] At Siteman he leads efforts to promote cancer prevention in the community[11]

Awards and honors

[edit]
  • 1975 National Heart Foundation of Australia Scholarship
  • 1976 National Heart Foundation of Australia Scholarship
  • 1977 Asthma Foundation of Queensland Medical Scholarship
  • 1977 Australian Medical Students' Association—Eli Lilly Research Fellowship
  • 1981-82 Fulbright Postgraduate Student Award
  • 1981-83 Frank Knox Memorial Fellowship, Harvard University
  • 1991-96 American Cancer Society, Faculty Research Award
  • 1997 Raine Visiting professor, Department of Public Health, University of Western Australia
  • 1998 Visiting Scientist, Cancer Foundation of Western Australia
  • 1999 Leonard S. Schuman Lecture, University of Michigan
  • 2002 Rotan Lecture, MD Anderson Cancer Center
  • 2003 AACR-DeWitt S. Goodman Memorial Lectureship
  • 2004 American Society for Preventive Oncology, Distinguished Achievement Award
  • 2005 Cassel Distinguished Lecturer, University of North Carolina, Chapel Hill, Lineberger Comprehensive Cancer Center
  • 2006 Institute of Medicine, Member
  • 2007 Academy of Science, St. Louis, Fellow
  • 2008 Kaner Memorial Lecture, Norris Cotton Cancer Center, Dartmouth College
  • 2009 Harvard School of Public Health, Alumni Award of Merit[12]
  • 2011 American Cancer Society Medal of Honor[13]
  • 2012 AACR- ACS award for excellence in cancer epidemiology and prevention[14]
  • 2014 American Society of Clinical Oncology-American Cancer Society Award[15]
  • 2014 Newington Medalist – International[16]
  • 2014 LessCancer.org National Cancer Prevention Day Ronald B. Herberman Speaker
  • 2016 Highly Cited Researchers (h>100) according to their Google Scholar Citations public profiles. Rank 1. Graham Colditz. January 2016 edition 2016.1.1
  • 2018 Daniel P. Schuster Award for Distinguished Work in Clinical and Translational Science, Washington University School of Medicine
  • 2018 Fellow, American Association for the Advancement of Science
  • 2020 Washington University School of Medicine Academy of Educators
  • 2020 American College of Epidemiology's Lilienfeld Award
  • 2021 AACR Distinguished Lectureship on the Science of Cancer Health Disparities
  • 2021 Lifetime Membership of the Australasian Epidemiological Association
  • 2022 The University of Queensland Alumnus of the Year

References

[edit]
  1. ^ "Colditz, Graham".
  2. ^ "Home". mphs.wustl.edu.
  3. ^ "Cancer and the public health | Digital Outlook".
  4. ^ "Home". cancernewsincontext.org.
  5. ^ "Graham Colditz, MD, DrPH". Google Scholar. Retrieved 22 March 2023.
  6. ^ Adverse Effects of Vaccines: Evidence and Causality. Washington, D.C.: National Academies Press. 26 March 2012. pp. v, vi. doi:10.17226/13164. ISBN 978-0-309-21435-3.
  7. ^ Newington College Register of Past Students 1863-1998 (Syd, 1999) pp39
  8. ^ "Graham A. Colditz MD, DRPH". Archived from the original on 5 February 2012. Retrieved 4 August 2012.
  9. ^ "Home". yourdiseaserisk.wustl.edu.
  10. ^ Colditz, Graham A.; Dart, Hank (2021). "Commentary: 20 years online with "Your Disease Risk"". Cancer Causes & Control. 32 (1): 5–11. doi:10.1007/s10552-020-01356-3. PMC 7796866. PMID 33068181. S2CID 223559879.
  11. ^ "Elimination of Cancer Disparities". Siteman Cancer Center.
  12. ^ "2009 Alumni Award of Merit Winner Graham Colditz - Alumni Stories - Harvard Public Health Magazine - Harvard School of Public Health". Archived from the original on 11 December 2012. Retrieved 4 August 2012.
  13. ^ "ACS Medal of Honor". Archived from the original on 12 September 2015. Retrieved 4 August 2012.
  14. ^ http://www.aacr.org/home/public--media/aacr-in-the-news.aspx?d=2734[permanent dead link]
  15. ^ "Colditz to be honored for cancer prevention efforts - the Source - Washington University in St. Louis". 19 March 2014.
  16. ^ Newington Medal International Retrieved 24 August 2022.
[edit]